CUE icon

Cue Biopharma

63 hedge funds and large institutions have $43M invested in Cue Biopharma in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$207K
Puts
$103K
Net Calls
Net Calls Change

Top Buyers

1 +$489K
2 +$473K
3 +$445K
4
Citadel Advisors
Citadel Advisors
Florida
+$320K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$314K

Top Sellers

1 -$2.46M
2 -$411K
3 -$396K
4
BL
Bleichroeder LP
New York
-$379K
5
Renaissance Technologies
Renaissance Technologies
New York
-$323K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.58M
2
$5.9M
3
$4.11M
4
$2.7M
5
$2.37M
6
$1.95M
7
$1.71M
8
$1.66M
9
$1.62M
10
$1.23M
11
$1.09M
12
$918K
13
$907K
14
$789K
15
$598K
16
$536K
17
$523K
18
$504K
19
$473K
20
$446K
21
$377K
22
$353K
23
$333K
24
$280K
25
$272K